NASDAQ:IRON • US2546041011
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DISC MEDICINE INC (IRON).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-27 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-17 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-02-17 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-17 | Stifel | Maintains | Buy -> Buy |
| 2026-02-17 | Wedbush | Maintains | Outperform -> Outperform |
| 2026-02-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-03 | Stifel | Reiterate | Buy |
| 2025-10-30 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-17 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-10-17 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-10-17 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-21 | Truist Securities | Initiate | Buy |
| 2025-07-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-11 | Raymond James | Reiterate | Strong Buy |
| 2025-05-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-18 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-03-03 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-01-24 | Stifel | Maintains | Buy -> Buy |
| 2025-01-22 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 101.57% | N/A 437.67% | N/A 100.25% | N/A 91.17% | N/A 43.74% | N/A 31.67% | N/A 31.41% | ||||||||
| EBITDA YoY % growth | N/A | N/A | -68.47M -55.78% | -47.39M 30.79% | -91.025M -92.08% | -129.564M -42.34% | -235.741M -81.95% | N/A -21.56% | N/A -19.68% | N/A 3.88% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -810K | -68.7M -8,381.48% | -47.48M 30.89% | -91.125M -91.92% | -129.72M -42.35% | -236.022M -81.95% | N/A -28.00% | N/A -6.68% | N/A 62.93% | N/A -10.46% | N/A 145.84% | N/A 301.95% | N/A 75.20% | N/A 73.26% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -18.10 67.85% | N/A 71.34% | -3.42 34.06% | -3.99 -16.67% | -6.01 -50.63% | N/A -20.54% | N/A -5.86% | N/A 23.93% | N/A 46.70% | N/A 153.96% | N/A 359.70% | N/A 27.45% | N/A 23.16% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -1.73 -69.78% | -1.78 -12.70% | -1.56 11.90% | -1.53 6.94% |
| Revenue Q2Q % growth | 396.668K | 1.077M | 10.258M | 17.952M |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -70.839M -77.34% | -72.973M -18.83% | -63.597M 6.06% | -66.402M 0.85% |
All data in USD
19 analysts have analysed IRON and the average price target is 104.64 USD. This implies a price increase of 62.43% is expected in the next year compared to the current price of 64.42.
DISC MEDICINE INC (IRON) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of DISC MEDICINE INC (IRON) is -1.73 USD and the consensus revenue estimate is 396.67K USD.
The number of analysts covering DISC MEDICINE INC (IRON) is 19.